Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
No element in selection
Contact

1 result

Active substance : sirolimus
Active substance : ivabradine
Active substance : acide salicylique
Topics : Economics and public health
Topics : Protheses and implants
Type : Drugs, devices and medical acts
Type : Health technology assessment

Topic

Economics and public health (1)
Plus ...
- Health economics (1)
Diagnostic and therapeutic techniques (1)
Plus ...
- Protheses and implants (1)
Diseases and conditions (1)
Plus ...
- Heart diseases (1)
- Plus ...
  - Myocardial ischemia (1)

Drugs, devices and medical acts (1)
Plus ...
- Health technology assessment (1)

industriels (1)

Français (1)

Active substance

acide salicylique (1)
aspirine (1)
bivalirudine (1)
chrome (1)
clopidogrel (1)
cobalt (1)
ivabradine (1)
paclitaxel (1)
prasugrel (1)
sirolimus (1)

Drugs, devices and medical acts

Première page
Page précédente
/ 1
Page suivante
Dernière page

Sorted by :Relevance

Title
Date

Assessment of drug-eluting stents

Health technology assessment - Posted on 19/02/2010

Download document

Add to my selection

Première page
Page précédente
/ 1
Page suivante
Dernière page
20 par pages

Advancing quality in the fields of health and social care services

Follow us :

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

ZqM4pBnyUtF3QvCG